Hot Pursuit     28-Mar-24
Alkem Labs slips after Baddi facility gets 10 observations from USFDA
Alkem Laboratories declined 2.05% to Rs 4,874.25 after the US Food and Drug Administration (USFDA) conducted GMP and Pre-approval inspection at its manufacturing facility located in Baddi, Himachal Pradesh.
The inspection was conducted from 19 March 2024 to 27 March 2024. At the end of the inspection, the company has received Form 483 with 10 observations.

The company said that this inspection is part of the routine business operations and it shall submit to US FDA within the stipulated timeline, a detailed response to close out the said observations.

Alkem Laboratories is engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs), and nutraceuticals.

The pharma major's consolidated net profit rose 30.84% to Rs 594.96 crore on 9.31% increase in net sales to Rs 3323.87 crore in Q3 December 2023 over Q3 December 2022.

Previous News
  Alkem Laboratories fixes record date for final dividend
 ( Market Beat - Reports 29-May-24   14:10 )
  USFDA concludes inspection of Alkem's Baddi unit
 ( Corporate News - 25-Jun-24   12:09 )
  Volumes spurt at Alkem Laboratories Ltd counter
 ( Hot Pursuit - 26-Feb-24   14:30 )
  Zydus Lifesciences Ltd Slides 1.88%
 ( Hot Pursuit - 18-Jun-24   09:30 )
  Alkem Laboratories consolidated net profit declines 34.02% in the March 2023 quarter
 ( Results - Announcements 19-May-23   14:16 )
  Indices trade with major gains; financial services edge higher
 ( Market Commentary - Mid-Session 25-Jun-24   14:32 )
  Board of Alkem Laboratories appoints CEO
 ( Corporate News - 15-Sep-23   13:53 )
  Alkem Laboratories Ltd spurts 0.14%, up for five straight sessions
 ( Hot Pursuit - 03-May-23   13:00 )
  Alkem Lab Q4 PAT drops 34% YoY to Rs 71 cr
 ( Hot Pursuit - 19-May-23   14:59 )
  Alkem Laboratories Ltd soars 1.6%, rises for third straight session
 ( Hot Pursuit - 17-May-24   13:05 )
  Alkem Laboratories consolidated net profit rises 124.64% in the June 2023 quarter
 ( Results - Announcements 12-Aug-23   13:47 )
Other Stories
  RVNL gains on emerging as L-1 bidder for Rs 133-cr railway project
  03-Jul-24   15:38
  Cholamandalam Financial Holdings Ltd leads losers in 'A' group
  03-Jul-24   15:00
  Sakuma Exports Ltd leads losers in 'B' group
  03-Jul-24   14:45
  NTPC power generation climbs 9.5% YoY in Q1
  03-Jul-24   14:41
  Volumes soar at MMTC Ltd counter
  03-Jul-24   14:30
  Oil and Gas shares fall
  03-Jul-24   14:00
  Real Estate stocks edge lower
  03-Jul-24   14:00
  Energy stocks edge lower
  03-Jul-24   14:00
  Sundaram-Clayton gains after board OKs to raise funds upto Rs 400 cr
  03-Jul-24   13:38
  JSW Infra's subsidiary concession agreement V.O. Chidambaranar Port Authority
  03-Jul-24   13:34
Back Top